These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6527242)

  • 21. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
    Lam XM; Duenas ET; Cleland JL
    J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Low dose of disulfiram and l-dopa evoked synergistic modification in behavior of Wistar and WAG/Rij rats].
    Getsova VM; Orlova NV; Folomkina AA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(5):656-62. PubMed ID: 14658332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells.
    Wang Z; Tan J; McConville C; Kannappan V; Tawari PE; Brown J; Ding J; Armesilla AL; Irache JM; Mei QB; Tan Y; Liu Y; Jiang W; Bian XW; Wang W
    Nanomedicine; 2017 Feb; 13(2):641-657. PubMed ID: 27521693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-week in vivo sustained release of a peptide formulated into in situ forming implants.
    Parent M; Clarot I; Gibot S; Derive M; Maincent P; Leroy P; Boudier A
    Int J Pharm; 2017 Apr; 521(1-2):357-360. PubMed ID: 28232200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury.
    Stanwick JC; Baumann MD; Shoichet MS
    Int J Pharm; 2012 Apr; 426(1-2):284-290. PubMed ID: 22306041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dietary disulfiram upon the tissue distribution and excretion of 14C-1,2-dibromoethane in the rat.
    Plotnick HB; Weigel WW; Richards DE; Cheever KL
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):535-45. PubMed ID: 392662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
    Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
    Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
    Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disulfiram implants. Lack of pharmacological and clinical effects].
    Johnsen J; Mørland J
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1229-30. PubMed ID: 2185582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient management in disulfiram implant therapy.
    Wilson A
    Can J Psychiatry; 1979 Oct; 24(6):537-41. PubMed ID: 487347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
    Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram implant: a controlled trial.
    Whyte CR; O'Brien PM
    Br J Psychiatry; 1974 Jan; 124(578):42-4. PubMed ID: 4595630
    [No Abstract]   [Full Text] [Related]  

  • 36. [Abstinence behavior and plasma concentration of disulfiram in alcoholics after esperal implantation].
    Boss D; Sauter A; Cornu F
    Schweiz Med Wochenschr; 1976 Aug; 106(32):1074-7. PubMed ID: 1006231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
    Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
    Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of sustained release microparticles with improved initial release property.
    Jung GY; Na YE; Park MS; Park CS; Myung PK
    Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gentamicin extended release from an injectable polymeric implant.
    Krasko MY; Golenser J; Nyska A; Nyska M; Brin YS; Domb AJ
    J Control Release; 2007 Jan; 117(1):90-6. PubMed ID: 17150275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained release of insulin by double-layered implant using poly(D,L-lactic acid).
    Yamakawa I; Kawahara M; Watanabe S; Miyake Y
    J Pharm Sci; 1990 Jun; 79(6):505-9. PubMed ID: 2203895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.